Back to News
Market Impact: 0.1
Wednesday 10/14 Insider Buying Report: RTSN, EDRY
Source: Nasdaq
Insider Transactions
The article introduces two recent insider buys, noting that an SEC filing showed a Tuesday transaction at Retension Pharmaceuticals. The supplied text cuts off before identifying the executive or providing the transaction size and other details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Why is Rocket Lab stock tumbling today?
- Citizens reiterates Kura Oncology stock rating on diabetes data
- Joby Aviation CLO Kate DeHoff sells $42,140 in shares
- California Resources EVP Jay Bys sells $642,978 in shares
- Palvella Therapeutics director George M. Jenkins disposes of $3.58m PVLA stock
- Cue Biopharma VP Meluzio sells $32,089 in Cue stock for tax